Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2006 1
2007 1
2008 3
2009 5
2010 2
2011 6
2012 4
2013 11
2014 5
2015 3
2016 4
2017 5
2018 5
2019 7
2020 8
2021 7
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease.
Pugliese D, Privitera G, Pizzolante F, Gasbarrini A, Guidi L, Armuzzi A. Pugliese D, et al. Among authors: guidi l. Minerva Gastroenterol Dietol. 2019 Dec;65(4):280-290. doi: 10.23736/S1121-421X.19.02625-4. Epub 2019 Oct 24. Minerva Gastroenterol Dietol. 2019. PMID: 31646853 Review.
Ileal Crohn's disease: CEUS determination of activity.
De Franco A, Marzo M, Felice C, Pugliese D, Veronica AD, Bonomo L, Armuzzi A, Guidi L. De Franco A, et al. Among authors: guidi l. Abdom Imaging. 2012 Jun;37(3):359-68. doi: 10.1007/s00261-011-9831-9. Abdom Imaging. 2012. PMID: 22223202 Review.
Management of perianal fistulas in Crohn's disease: an up-to-date review.
Marzo M, Felice C, Pugliese D, Andrisani G, Mocci G, Armuzzi A, Guidi L. Marzo M, et al. Among authors: guidi l. World J Gastroenterol. 2015 Feb 7;21(5):1394-403. doi: 10.3748/wjg.v21.i5.1394. World J Gastroenterol. 2015. PMID: 25663759 Free PMC article. Review.
Incident Colorectal Cancer in Inflammatory Bowel Disease.
Neri B, Scribano ML, Armuzzi A, Castiglione F, D'Incà R, Orlando A, Festa S, Riegler G, Fries W, Meucci G, Alvisi P, Mocciaro F, Papi C, Mossa M, Sena G, Guidi L, Testa A, Renna S, Frankovic I, Viola A, Patturelli M, Chiaramonte C, Biancone L, On Behalf Of Ig-Ibd Italian Group For The Study Of Inflammatory Bowel Disease. Neri B, et al. Among authors: guidi l. Cancers (Basel). 2022 Jan 30;14(3):721. doi: 10.3390/cancers14030721. Cancers (Basel). 2022. PMID: 35158989 Free PMC article.
78 results